Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myeloid, Acute 6Breast Neoplasms 5Lymphoma, Follicular 4Neuroblastoma 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Lymphocytic, Chronic, B-Cell 3Burkitt Lymphoma 3Waldenstrom Macroglobulinemia 2Recurrence 2Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hodgkin Disease 2Breast Neoplasms, Male 2Warts 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Osteosarcoma 1Optic Nerve Glioma 1

Interventions

Cyclophosphamide 10Docetaxel 6Trastuzumab 5Radiotherapy 5Tamoxifen 4Neoadjuvant Therapy 4Filgrastim 4Doxorubicin 4tipifarnib 3Peripheral Blood Stem Cell Transplantation 3Epirubicin 3Thiotepa 2Radiation 2Paclitaxel 2Fluorouracil 2Chemotherapy, Adjuvant 2Carboplatin 2Capecitabine 2Bevacizumab 2pegfilgrastim 1olaparib 1cediranib 1aldesleukin 1Therapeutics 1Taxes 1Specimen Handling 1Razoxane 1Methotrexate 1Mesna 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Inflammatory Breast Neoplasms × Granulocyte Colony-Stimulating Factor × Clear all
NCT00049114 2013-06-06

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
62 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡